193 related articles for article (PubMed ID: 26821710)
1. Effects of Mecp2 loss of function in embryonic cortical neurons: a bioinformatics strategy to sort out non-neuronal cells variability from transcriptome profiling.
Vacca M; Tripathi KP; Speranza L; Aiese Cigliano R; Scalabrì F; Marracino F; Madonna M; Sanseverino W; Perrone-Capano C; Guarracino MR; D'Esposito M
BMC Bioinformatics; 2016 Jan; 17 Suppl 2(Suppl 2):14. PubMed ID: 26821710
[TBL] [Abstract][Full Text] [Related]
2. Astrocyte Transcriptome from the Mecp2(308)-Truncated Mouse Model of Rett Syndrome.
Delépine C; Nectoux J; Letourneur F; Baud V; Chelly J; Billuart P; Bienvenu T
Neuromolecular Med; 2015 Dec; 17(4):353-63. PubMed ID: 26208914
[TBL] [Abstract][Full Text] [Related]
3. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology.
Ballas N; Lioy DT; Grunseich C; Mandel G
Nat Neurosci; 2009 Mar; 12(3):311-7. PubMed ID: 19234456
[TBL] [Abstract][Full Text] [Related]
4. Neuronal morphology in MeCP2 mouse models is intrinsically variable and depends on age, cell type, and Mecp2 mutation.
Wang IT; Reyes AR; Zhou Z
Neurobiol Dis; 2013 Oct; 58():3-12. PubMed ID: 23659895
[TBL] [Abstract][Full Text] [Related]
5. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of
Pacheco NL; Heaven MR; Holt LM; Crossman DK; Boggio KJ; Shaffer SA; Flint DL; Olsen ML
Mol Autism; 2017; 8():56. PubMed ID: 29090078
[TBL] [Abstract][Full Text] [Related]
6. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate.
Maezawa I; Jin LW
J Neurosci; 2010 Apr; 30(15):5346-56. PubMed ID: 20392956
[TBL] [Abstract][Full Text] [Related]
7. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological reactivation of inactive X-linked
Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome.
Ehinger Y; Matagne V; Cunin V; Borloz E; Seve M; Bourgoin-Voillard S; Borges-Correia A; Villard L; Roux JC
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919253
[TBL] [Abstract][Full Text] [Related]
10. MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain.
Nguyen MV; Du F; Felice CA; Shan X; Nigam A; Mandel G; Robinson JK; Ballas N
J Neurosci; 2012 Jul; 32(29):10021-34. PubMed ID: 22815516
[TBL] [Abstract][Full Text] [Related]
11. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions.
Maezawa I; Swanberg S; Harvey D; LaSalle JM; Jin LW
J Neurosci; 2009 Apr; 29(16):5051-61. PubMed ID: 19386901
[TBL] [Abstract][Full Text] [Related]
12. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
13. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
Braunschweig D; Simcox T; Samaco RC; LaSalle JM
Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional differences in the barrel cortex of Mecp2 null mice.
Lee LJ; Tsytsarev V; Erzurumlu RS
J Comp Neurol; 2017 Dec; 525(18):3951-3961. PubMed ID: 28857161
[TBL] [Abstract][Full Text] [Related]
15. Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome.
Okabe Y; Takahashi T; Mitsumasu C; Kosai K; Tanaka E; Matsuishi T
PLoS One; 2012; 7(4):e35354. PubMed ID: 22532851
[TBL] [Abstract][Full Text] [Related]
16. Biotin tagging of MeCP2 in mice reveals contextual insights into the Rett syndrome transcriptome.
Johnson BS; Zhao YT; Fasolino M; Lamonica JM; Kim YJ; Georgakilas G; Wood KH; Bu D; Cui Y; Goffin D; Vahedi G; Kim TH; Zhou Z
Nat Med; 2017 Oct; 23(10):1203-1214. PubMed ID: 28920956
[TBL] [Abstract][Full Text] [Related]
17. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
18. The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes.
Scaramuzza L; De Rocco G; Desiato G; Cobolli Gigli C; Chiacchiaretta M; Mirabella F; Pozzi D; De Simone M; Conforti P; Pagani M; Benfenati F; Cesca F; Bedogni F; Landsberger N
EMBO Mol Med; 2021 Apr; 13(4):e12433. PubMed ID: 33665914
[TBL] [Abstract][Full Text] [Related]
19. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks.
Belichenko PV; Wright EE; Belichenko NP; Masliah E; Li HH; Mobley WC; Francke U
J Comp Neurol; 2009 May; 514(3):240-58. PubMed ID: 19296534
[TBL] [Abstract][Full Text] [Related]
20. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
